While medical cannabis products are increasingly prescribed for patients with chronic health conditions in the UK and internationally, many physicians remain cautious about prescribing....

Autism spectrum disorder (autism) is a neurodevelopmental condition, caused by differences in the brain and characterised by differences in social communication and interaction, and...

Cannabis Sativa is a complex plant containing hundreds of active components, including cannabinoids, terpenes, flavonoids and more. Medical cannabis research, primarily into cannabidiol (CBD)...

On 25th June 2018, the US Food and Drug Administration (FDA) approved Epidiolex, a cannabidiol (CBD)-based prescription medication, making it the first cannabis-based product...

Back pain is the leading cause of years lived with disability in industrialised countries, with the annual prevalence of low back pain (LBP) being...

Osteoarthritis (OA) is the most common of arthritic conditions. It is estimated to affect around 10 million people in the UK alone and is...

In recent years, interest in the therapeutic potential of cannabidiol (CBD) has skyrocketed. The cannabinoid has been investigated in various medical conditions and disorders,...

Poor sleep is associated with several health problems, including hypertension, diabetes, obesity, depression, heart attack, and stroke. Sleep problems, including difficulties getting to sleep...

Inflammatory Bowel Disease (IBD), including Crohn’s disease (CD) and ulcerative colitis (UC) are conditions that are characterised by chronic inflammation of the gastrointestinal (GI)...